AMICUS THERAPEUTICS, INC. Net Change in Cash
AMICUS THERAPEUTICS, INC. reported Net Change in Cash of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$31.98M.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$37.28M, a 414.15% decline year-over-year.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $11.87M.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$11.63M, a 153.15% decline year-over-year.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $600.00K.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$33.36M, a 134.41% decline from fiscal 2023.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $96.96M.
- AMICUS THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$96.34M, a 215.66% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-02-20 | |||
| 2025-09-30 | -$22.86M 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | -$54.70M 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | -$31.98M 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | -$33.36M 10-K · filed 2026-02-20 | |||
| 2024-09-30 | -$13.26M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | -$37.72M 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | -$37.28M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $96.96M 10-K · filed 2026-02-20 | |||
| 2023-09-30 | $113.16M 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $61.22M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $11.87M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$96.34M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | $32.08M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$9.60M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$11.63M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $83.29M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $222.91M 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $13.63M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $21.89M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $19.82M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $67.08M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $20.92M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$20.45M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $63.97M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $87.33M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $140.81M 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $16.55M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $31.14M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $152.59M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $24.20M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $65.31M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$136.18M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$121.84M 10-Q · filed 2018-11-05 | |||
| 2017-06-30 | -$149.63M 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | -$142.27M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $117.93M 10-K · filed 2019-02-28 |